Perma-Fix Subsidiary Adds Medical Industry Advisor

Perma-Fix Medical Services, a subsidiary of Perma-Fix Environmental Services, will add Stephen Belcher to its advisory board. Belcher, who has 19 years of nuclear pharmaceutical experience, has already provided “valuable strategic insight” while “bringing very deep industry relationships,” according to Perma-Fix CEO Lou Centofanti. Last week during a presentation in Poland, Centofanti had said that the company was looking to work with more medical industry partners to help bolster its Technetium-99m (Tc-99m) technology. “I am excited to join Perma-Fix Medical’s advisory board at this major inflection point,” Belcher said in a statement. “I believe the technology they developed has the potential to reshape the global supply chain of Tc-99m in the United States and around the world.  Perma-Fix Medical’s process addresses major environmental and political issues surrounding the current production method, which involves the use of weapons grade uranium.  Perma-Fix Medical’s process does not utilize any form of uranium, is cost effective and should help create a more reliable supply chain for Tc-99m around the world.”